These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 39032940)

  • 1. Proteomic and phenotypic characteristics of memory-like natural killer cells for cancer immunotherapy.
    Arellano-Ballestero H; Zubiak A; Dally C; Orchard K; Alrubayyi A; Charalambous X; Michael M; Torrance R; Eales T; Das K; Tran MGB; Sabry M; Peppa D; Lowdell MW
    J Immunother Cancer; 2024 Jul; 12(7):. PubMed ID: 39032940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures.
    Sabry M; Zubiak A; Hood SP; Simmonds P; Arellano-Ballestero H; Cournoyer E; Mashar M; Pockley AG; Lowdell MW
    PLoS One; 2019; 14(6):e0218674. PubMed ID: 31242243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokines induced memory-like NK cells engineered to express CD19 CAR exhibit enhanced responses against B cell malignancies.
    He B; Mai Q; Pang Y; Deng S; He Y; Xue R; Xu N; Zhou H; Liu X; Xuan L; Li C; Liu Q
    Front Immunol; 2023; 14():1130442. PubMed ID: 37207215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemia.
    Romee R; Rosario M; Berrien-Elliott MM; Wagner JA; Jewell BA; Schappe T; Leong JW; Abdel-Latif S; Schneider SE; Willey S; Neal CC; Yu L; Oh ST; Lee YS; Mulder A; Claas F; Cooper MA; Fehniger TA
    Sci Transl Med; 2016 Sep; 8(357):357ra123. PubMed ID: 27655849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotype and Function of Activated Natural Killer Cells From Patients With Prostate Cancer: Patient-Dependent Responses to Priming and IL-2 Activation.
    Hood SP; Foulds GA; Imrie H; Reeder S; McArdle SEB; Khan M; Pockley AG
    Front Immunol; 2018; 9():3169. PubMed ID: 30761160
    [No Abstract]   [Full Text] [Related]  

  • 6. Cytokine-induced memory-like natural killer cells have enhanced function, proliferation, and in vivo expansion against ovarian cancer cells.
    Uppendahl LD; Felices M; Bendzick L; Ryan C; Kodal B; Hinderlie P; Boylan KLM; Skubitz APN; Miller JS; Geller MA
    Gynecol Oncol; 2019 Apr; 153(1):149-157. PubMed ID: 30658847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical-grade ex vivo-expanded human natural killer cells up-regulate activating receptors and death receptor ligands and have enhanced cytolytic activity against tumor cells.
    Berg M; Lundqvist A; McCoy P; Samsel L; Fan Y; Tawab A; Childs R
    Cytotherapy; 2009; 11(3):341-55. PubMed ID: 19308771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine-Induced Memory-Like NK Cells: From the Basics to Clinical Applications.
    Terrén I; Orrantia A; Astarloa-Pando G; Amarilla-Irusta A; Zenarruzabeitia O; Borrego F
    Front Immunol; 2022; 13():884648. PubMed ID: 35603208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced expression of natural cytotoxicity receptors on cytokine-induced memory-like natural killer cells correlates with effector function.
    Carreira-Santos S; López-Sejas N; González-Sánchez M; Sánchez-Hernández E; Pera A; Hassouneh F; Durán E; Solana R; Casado JG; Tarazona R
    Front Immunol; 2023; 14():1256404. PubMed ID: 37908353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine-Induced Memory-Like Differentiation Enhances Unlicensed Natural Killer Cell Antileukemia and FcγRIIIa-Triggered Responses.
    Wagner JA; Berrien-Elliott MM; Rosario M; Leong JW; Jewell BA; Schappe T; Abdel-Latif S; Fehniger TA
    Biol Blood Marrow Transplant; 2017 Mar; 23(3):398-404. PubMed ID: 27894857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. iRGD-modified memory-like NK cells exhibit potent responses to hepatocellular carcinoma.
    Dong Y; Huang Y; Zhang Z; Chen A; Li L; Tian M; Shen J; Shao J
    J Transl Med; 2023 Mar; 21(1):205. PubMed ID: 36932395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PM21-particle stimulation augmented with cytokines enhances NK cell expansion and confers memory-like characteristics with enhanced survival.
    Oyer JL; Croom-Perez TJ; Hasan MF; Rivera-Huertas JA; Gitto SB; Mucha JM; Zhu X; Altomare DA; Igarashi RY; Copik AJ
    Front Immunol; 2024; 15():1383281. PubMed ID: 38711506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural killer cell-based adoptive immunotherapy eradicates and drives differentiation of chemoresistant bladder cancer stem-like cells.
    Ferreira-Teixeira M; Paiva-Oliveira D; Parada B; Alves V; Sousa V; Chijioke O; Münz C; Reis F; Rodrigues-Santos P; Gomes C
    BMC Med; 2016 Oct; 14(1):163. PubMed ID: 27769244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimizing NK Cell-Based Immunotherapy in Myeloid Leukemia: Abrogating an Immunosuppressive Microenvironment.
    Kaweme NM; Zhou F
    Front Immunol; 2021; 12():683381. PubMed ID: 34220833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Semaphorin 7A modulates cytokine-induced memory-like responses by human natural killer cells.
    Ghofrani J; Lucar O; Dugan H; Reeves RK; Jost S
    Eur J Immunol; 2019 Aug; 49(8):1153-1166. PubMed ID: 31016720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokine-induced memory-like natural killer cells for cancer immunotherapy.
    Tarannum M; Romee R
    Stem Cell Res Ther; 2021 Dec; 12(1):592. PubMed ID: 34863287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of natural killer and natural killer-like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: implications for adoptive cellular immunotherapy.
    Ayello J; van de Ven C; Cairo E; Hochberg J; Baxi L; Satwani P; Cairo MS
    Exp Hematol; 2009 Oct; 37(10):1216-29. PubMed ID: 19638292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Fusion Protein Complex that Combines IL-12, IL-15, and IL-18 Signaling to Induce Memory-Like NK Cells for Cancer Immunotherapy.
    Becker-Hapak MK; Shrestha N; McClain E; Dee MJ; Chaturvedi P; Leclerc GM; Marsala LI; Foster M; Schappe T; Tran J; Desai S; Neal CC; Pence P; Wong P; Wagner JA; Russler-Germain DA; Zhu X; Spanoudis CM; Gallo VL; Echeverri CA; Ramirez LL; You L; Egan JO; Rhode PR; Jiao JA; Muniz GJ; Jeng EK; Prendes CA; Sullivan RP; Berrien-Elliott MM; Wong HC; Fehniger TA
    Cancer Immunol Res; 2021 Sep; 9(9):1071-1087. PubMed ID: 34244297
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Guo X; Mahlakõiv T; Ye Q; Somanchi S; He S; Rana H; DiFiglia A; Gleason J; van der Touw W; Hariri R; Zhang X
    J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33741730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ex vivo expanded allogeneic natural killer cells have potent cytolytic activity against cancer cells through different receptor-ligand interactions.
    Jung D; Baek YS; Lee IJ; Kim KY; Jang H; Hwang S; Jung J; Moon YW; Park KS; Choi YS; An HJ
    J Exp Clin Cancer Res; 2021 Oct; 40(1):333. PubMed ID: 34686187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.